Access

Genomics should be available to the many, not the few. It has the power to save lives and vastly improve the human condition. As the leader in genomics, we have the obligation to drive down the cost of sequencing, expand access to diagnostics technology, and increase the diversity of genomics data to realize health equity for billions of people around the world.

Videos from this campaign

Stephanie Lheureux, MD, PhD,Princess Margaret Cancer Centre (PMCC).
Illumina Booth at UK Festival of Genomics & Biodata

Content from this campaign

Health & Healthcare

Illumina Unveils Groundbreaking Comprehensive Genomic Profiling Test for Cancer in Europe
Illumina, Inc. (NASDAQ:ILMN) today announced the launch of TruSight™ Oncology (TSO) Comprehensive (EU), a single test that assesses multiple tumor genes and biomarkers to reveal the specific molecular profile of a patient's cancer.

Health & Healthcare

Illumina and Trivitron Partner to Accelerate Disease Detection and Diagnosis for Patients in India
Illumina Singapore, subsidiary of Illumina Inc (NASDAQ: ILMN) and Trivitron Healthcare, one of India's largest medical technology companies, have entered into a strategic partnership to develop and expand the use of next-generation sequencing (NGS)-based in-vitro diagnostic tests (IVD) in India.

Awards, Ratings & Rankings

Illumina Named One of Fast Company's Most Innovative Companies for 2022
We are honored to have been named one of Fast Company’s Most Innovative Companies for 2022.

Health & Healthcare

Illumina Celebrates Rare Disease Day
Today and everyday, Illumina recognizes Rare Disease Day 2022.

Health & Healthcare

Growing Grassroots Support for the Rare Disease Community in Romania
In 2007, Dorica Dan, the mother of a child with the rare disease Prader Willi Syndrome, envisioned the first and only patient-run reference center for rare diseases in Europe.

Research, Reports & Publications

New Study Demonstrates That Whole Genome Sequencing Can Be Used As a Routine Diagnostic for Patients With Neurological Disorders
A study published in Lancet Neurology, led by Genomics England in collaboration with Illumina, demonstrates that whole genome sequencing (WGS) can be used as a routine diagnostic for patients with neurological disorders.

Health & Healthcare

“The World Expands”: Celebrating Rare Disease Day in Japan
The kids in Kanade Kawagoe’s elementary school class were excited to see a Polaroid camera for the first time.

Philanthropy & Cause Initiatives

African Coronavirus Surveillance Network Provides Early Warning for World
As part of the support, Illumina pledged $20 million over four years to help strengthen #sequencing technology for 20 African countries.

Health & Healthcare

Illumina to Support Neuro Genomics Project at McGill University
Today, the Montreal Neurological Institute-Hospital at McGill University (The Neuro) announced a new research collaboration with Illumina, along with Takeda Development Center Americas, Inc., and pharmaceutical powerhouse Roche.

Health & Healthcare

Patient Success Story: Beating Stage IV Lung Cancer
Eight years ago, AJ Patel was diagnosed with advanced lung cancer.
Illumina logo

More from Illumina

  1. Business
    At Illumina, the faster we can innovate, the more lives we can help save. As a genomics pioneer, we have proven through focused and continued...

  2. People
    Harnessing the world’s best talent and giving them the opportunity to thrive allows us to make world-changing leaps in human health and beyond. Our...

  3. Access
    Genomics should be available to the many, not the few. It has the power to save lives and vastly improve the human condition. As the leader in...

  4. Community
    By sharing our time, talent, and technology, we aim to inspire, support, and empower our communities, our employees, and the next generation.

  5. Environment
    We are committed to integrating environmental stewardship into the way we operate. We recognize the importance of the environment in creating a...

  6. Operating Responsibly
    Our role as a genomics pioneer brings with it the responsibility to enable innovation for good, ensuring that the technology we create and the data we...